ESC 365 - First experience with a patch infusor for subcutaneous administration of a novel furosemide formulation.

HFA Premium Access

First experience with a patch infusor for subcutaneous administration of a novel furosemide formulation.

Session: Furosemide 2.0 - Subcutaneous administration of a novel formulation

Topic: Acute Heart Failure

Speaker: Professor J. Udelson (Boston, US)

Sponsored by scPharmaceuticals

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Professor James E Udelson

Tufts Medical Center, Inc., Boston (United States of America)

7 presentations

0 follower

2 more presentations in this session

Health policy and economics related to treatment of fluid overload in heart failure.

Speaker: Doctor P. Muntendam (Burlington, US)

Rationale for a new furosemide product 50 years after its first introduction.

Speaker: Professor R. De Boer (Rotterdam, NL)

Access the full session

Furosemide 2.0 - Subcutaneous administration of a novel formulation

Speakers: Professor J. Udelson, Doctor P. Muntendam, Professor R. De Boer

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by